News

kPituitary Tumor Center, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea lDepartment of Internal Medicine, Seoul National University College of Medicine, Seoul, South ...
Mumbai: Maharashtra Chief Minister Eknath Shinde and Deputy Chief Minister Devendra Fadnavis inaugurated Phase 2A of Mumbai Metro Line 3 on Friday, marking a significant milestone in the city’s ...
These version 3.3 Phase 1 Banners start on Wednesday 21st May and are expected to end on Wednesday 11th June. These version 3.3 Phase 2 Banners are expected to run from Wednesday 11th June to ...
I congratulate and thank our team at Morton Plant Hospital for achieving this important milestone in enrolling the first patient in the world’s first confirmatory Phase 3 cardiac cell therapy ...
According to DOTD, motorists will see more changes this week. The I-20 project is in phase 3, meaning drivers are closer than ever to being able to drive on a resurfaced interstate. "So I-20 is ...
It’s been eight months since the Union government approved two corridors under Bengaluru Metro Phase 3 at an estimated cost of Rs 15,611 crore, but Bangalore Metro Rail Corporation Ltd (BMRCL ...
I don't think Merck's market cap will double by 2030. But an up-and-coming ... VK2735. There's a phase 3 trial which will begin later this year, testing its effectiveness as a treatment for ...
Meanwhile, the food maker's stock is down 25% and its dividend yield is historically high at 3.3%, suggesting it has been put in the discount bin.
Credit: SpaceX COLORADO SPRINGS — The U.S. Space Force’s Systems Command has assigned the first nine National Security Space Launch (NSSL) missions under the Phase 3 Lane 2 contracts ...
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today reported that clinical trial site activation for enrollment is underway for the company’s Phase 3 program evaluating zaltenibart ...
--(BUSINESS WIRE)--Incyte (Nasdaq: INCY) today announced positive topline results from its pivotal Phase 3 STOP-HS clinical ... Both studies include a 12-week double-blind, placebo-controlled ...
Results showed a greater percentage of povorcitinib-treated patients achieved HiSCR50 compared with placebo at week 12. Topline data were announced from two pivotal phase 3 studies evaluating ...